[ad_1] NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR). Such investors are advised to contact Danielle Peyton at [email protected] or […]

[ad_1] NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Stellantis N.V. (“Stellantis” or the “Company”) (NYSE: STLA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. […]

[ad_1] NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of General Motors Company (“GM” or the “Company”) (NYSE: GM). Such investors are advised to contact Danielle Peyton at […]

[ad_1] NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Agenus Inc. (“Agenus” or the “Company”) (NASDAQ: AGEN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, […]

[ad_1] NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Caribou Biosciences, Inc. (“Caribou” or the “Company”) (NASDAQ: CRBU). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, […]